A Novel Method of Imaging Calcium Urolithiasis Using Fluorescence

Journal of Urology

Volumn 179, Issue 4, 2008, Pages 1610-1614

  Figueiredo, Jose Luiz ^a   Passerotti, Carlo C ^a   Sponholtz, Todd ^a   Nguyen, Hiep T ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

diagnostic imaging; fluorescence; mice; molecular probes; urinary calculi

Indexed keywords

AMMONIA; CALCIUM; CALCIUM OXALATE; CALCIUM PHOSPHATE; FLUORESCENT DYE; OSTEOSENSE 680; OSTEOSENSE 750; STRUVITE; UNCLASSIFIED DRUG; URATE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CALCIUM OXALATE STONE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FLUORESCENCE; KIDNEY PELVIS; MALE; MOLECULAR PROBE; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; STONE FORMATION; URINARY TRACT; UROLITHIASIS;

ANIMALS; CALCIUM; DISEASE MODELS, ANIMAL; FLUORESCENCE; MALE; MICE; UROLITHIASIS;

EID: 40849094314     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.11.100     Document Type: Article

References (14)

1. Finkielstein V.A., and Goldfarb D.S. Strategies for preventing calcium oxalate stones. CMAJ 174 (2006) 1407
2. Lingeman J.E., Kim S.C., Kuo R.L., McAteer J.A., and Evan A.P. Shockwave lithotripsy: anecdotes and insights. J Endourol 17 (2003) 687
3. Miller N.L., and Lingeman J.E. Management of kidney stones. BMJ 334 (2007) 468
4. Ahmad N.A., Ather M.H., and Rees J. Unenhanced helical computed tomography in the evaluation of acute flank pain. Int J Urol 10 (2003) 287
5. Heidenreich A., Desgrandschamps F., and Terrier F. Modern approach of diagnosis and management of acute flank pain: review of all imaging modalities. Eur Urol 41 (2002) 351
6. Zaheer A., Lenkinski R.E., Mahmood A., Jones A.G., Cantley L.C., and Frangioni J.V. In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol 19 (2001) 1148
7. Wolf Jr. J.S., Irby III P.B., Shields A., Yuen-Green M.S., Hattner R.S., and Stoller M.L. Urolithoscintigraphy: preliminary report of a new imaging modality for urolithiasis. J Endourol 8 (1994) 133
8. Coe F.L., Evan A., and Worcester E. Kidney stone disease. J Clin Invest 115 (2005) 2598
9. Wolf Jr. J.S., and Stoller M.L. Inhibition of calculi fragment growth by metal-bisphosphonate complexes demonstrated with a new assay measuring the surface activity of urolithiasis inhibitors. J Urol 152 (1994) 1609
10. Ntziachristos V., Bremer C., and Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13 (2003) 195
11. Nahrendorf M., Sosnovik D.E., Waterman P., Swirski F.K., Pande A.N., Aikawa E., et al. Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ Res 100 (2007) 1218
12. Sosnovik D., and Weissleder R. Magnetic resonance and fluorescence based molecular imaging technologies. Prog Drug Res 62 (2005) 83
13. Graves E.E., Yessayan D., Turner G., Weissleder R., and Ntziachristos V. Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography. J Biomed Opt 10 (2005) 44019
14. Zacharakis G., Ripoll J., Weissleder R., and Ntziachristos V. Fluorescent protein tomography scanner for small animal imaging. IEEE Trans Med Imaging 24 (2005) 878